Glycoproteomic analysis of plasma from patients with atopic dermatitis: CD5L and ApoE as potential biomarkers.

Authors: Kim, WK  Hwang, HR  Kim do, H  Lee, PY  In, YJ  Ryu, HY  Park, SG  Bae, KH  Lee, SC 
Citation: Kim WK, etal., Exp Mol Med. 2008 Dec 31;40(6):677-85.
Pubmed: (View Article at PubMed) PMID:19116453
DOI: Full-text: DOI:10.3858/emm.2008.40.6.677

Atopic dermatitis (AD) is an inflammatory skin disorder that is both uncomfortable and distressing to patients, and its prevalence has been steadily increasing. It is obvious that the identification of efficient markers of AD in plasma would offer the possibility of effective diagnosis, prevention, and treatment strategies. In this study, a proteomic approach was used to analyze plasma glycoproteins from both children with AD and healthy child donors. Several protein spots showing significant quantitative changes in the AD patients were identified. Through sequential studies, it was confirmed that CD5L and ApoE were significantly up-regulated or down-regulated, respectively, in the plasma from AD patients compared with that from healthy donors. In addition, we suggest that the up-regulated CD5L in AD patients causes eosinophilia by inhibiting apoptosis or promoting the proliferation of eosinophils either in combination with or without IL-5. The glycoproteomic data in this study provides clues to understanding the mechanism of atopic alterations in plasma and suggests AD-related proteins can be used as candidate markers for AD.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 11040546
Created: 2016-03-10
Species: All species
Last Modified: 2016-03-10
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.